A detailed history of Gw&K Investment Management, LLC transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,126,083 shares of PHAT stock, worth $8.45 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,126,083
Previous 600,443 87.54%
Holding current value
$8.45 Million
Previous $6.19 Million 229.18%
% of portfolio
0.17%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$10.25 - $19.5 $5.39 Million - $10.2 Million
525,640 Added 87.54%
1,126,083 $20.4 Million
Q2 2024

Aug 12, 2024

BUY
$8.97 - $12.05 $290,780 - $390,624
32,417 Added 5.71%
600,443 $6.19 Million
Q1 2024

May 08, 2024

BUY
$6.21 - $11.05 $40,588 - $72,222
6,536 Added 1.16%
568,026 $6.03 Million
Q4 2023

Feb 09, 2024

SELL
$6.99 - $10.71 $111,560 - $170,931
-15,960 Reduced 2.76%
561,490 $5.13 Million
Q3 2023

Nov 09, 2023

SELL
$10.26 - $15.7 $153,263 - $234,526
-14,938 Reduced 2.52%
577,450 $5.99 Million
Q2 2023

Aug 09, 2023

SELL
$7.28 - $14.32 $47,028 - $92,507
-6,460 Reduced 1.08%
592,388 $8.48 Million
Q1 2023

May 09, 2023

BUY
$6.19 - $12.36 $29,037 - $57,980
4,691 Added 0.79%
598,848 $4.28 Million
Q4 2022

Feb 10, 2023

BUY
$9.18 - $11.53 $9,161 - $11,506
998 Added 0.17%
594,157 $6.67 Million
Q3 2022

Nov 09, 2022

BUY
$6.46 - $12.11 $644,120 - $1.21 Million
99,709 Added 20.21%
593,159 $6.57 Million
Q2 2022

Aug 09, 2022

BUY
$6.2 - $15.5 $85,609 - $214,024
13,808 Added 2.88%
493,450 $4.17 Million
Q1 2022

May 09, 2022

BUY
$11.55 - $20.06 $1.11 Million - $1.93 Million
96,090 Added 25.05%
479,642 $6.53 Million
Q4 2021

Feb 11, 2022

BUY
$17.83 - $33.15 $2.83 Million - $5.26 Million
158,629 Added 70.53%
383,552 $7.54 Million
Q3 2021

Nov 10, 2021

SELL
$30.69 - $36.83 $137,951 - $165,550
-4,495 Reduced 1.96%
224,923 $7.22 Million
Q2 2021

Aug 10, 2021

BUY
$32.66 - $39.87 $976,533 - $1.19 Million
29,900 Added 14.99%
229,418 $7.77 Million
Q1 2021

May 11, 2021

BUY
$33.86 - $48.68 $6.76 Million - $9.71 Million
199,518 New
199,518 $7.49 Million

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $294M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.